Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-16-105356
Filing Date
2016-03-16
Accepted
2016-03-16 08:01:57
Documents
5
Effectiveness Date
2016-03-16

Document Format Files

Seq Description Document Type Size
1 S-8 a16-6374_1s8.htm S-8 120731
2 EX-5.1 a16-6374_1ex5d1.htm EX-5.1 14025
3 EX-23.2 a16-6374_1ex23d2.htm EX-23.2 3725
4 GRAPHIC g63741kei001.gif GRAPHIC 11946
5 GRAPHIC g63741kei002.jpg GRAPHIC 6310
  Complete submission text file 0001104659-16-105356.txt   164964
Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Filer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-210229 | Film No.: 161508557
SIC: 2834 Pharmaceutical Preparations